The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults
eLife · 03.05.2024 · 12
DOI: 10.7554/elife.89967 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 03.05.2024. Verfasst von Arya Y Nakhe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon, Glucose, Insulin Secretion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NCI NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The gain-of-function mutation in the TALK-1 K + channel (p.L114P) is associated with maturity-onset diabetes of the young (MODY). TALK-1 is a key regulator of β-cell electrical activity and glucose-stimulated insulin secretion. The KCNK16 gene encoding TALK-1 is the most abundant and β-cell-restricted K + channel transcript. To investigate the impact of KCNK16 L114P on glucose homeostasis and confirm its association with MODY, a mouse model containing the Kcnk16 L114P mutation was generated. Heterozygous and homozygous Kcnk16 L114P mice exhibit increased neonatal lethality in the C57BL/6J and the CD-1 (ICR) genetic background, respectively. Lethality is likely a result of severe hyperglycemia observed in the homozygous Kcnk16 L114P neonates due to lack of glucose-stimulated insulin secretion and can be reduced with insulin treatment. Kcnk16 L114P increased whole-cell β-cell K + currents resulting in blunted glucose-stimulated Ca 2+ entry and loss of glucose-induced Ca 2+ oscillations. Thus, adult Kcnk16 L114P mice have reduced glucose-stimulated insulin secretion and plasma insulin levels, which significantly impairs glucose homeostasis. Taken together, this study shows that the MODY-associated Kcnk16 L114P mutation disrupts glucose homeostasis in adult mice resembling a MODY phenotype and causes neonatal lethality by inhibiting islet insulin secretion during development. These data suggest that TALK-1 is an islet-restricted target for the treatment for diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, United States.
- Department of Chemistry, Vanderbilt University, Nashville, United States.
- Center for Stem Cell Biology, Vanderbilt University, Nashville, United States.
- Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States.
ORCID-Profile: Arya Y Nakhe, Mark A Magnuson, David A Jacobson
Förderung
- NIDDK NIH HHS
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Nakhe, A. Y., Dadi, P. K., Kim, J., Dickerson, M. T., Behera, S., Dobson, J. R., Shrestha, S., Cartailler, J. P., Sampson, L., Magnuson, M. A., & Jacobson, D. A. (2024). The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults. eLife, 12. https://doi.org/10.7554/elife.89967
Vancouver
Nakhe AY, Dadi PK, Kim J, Dickerson MT, Behera S, Dobson JR, et al. The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults. eLife. 2024;12. doi:10.7554/elife.89967
BibTeX
@article{Nakhe2024,
author = {Nakhe, Arya Y and Dadi, Prasanna K and Kim, Jinsun and Dickerson, Matthew T and Behera, Soma and Dobson, Jordyn R and Shrestha, Shristi and Cartailler, Jean-Philippe and Sampson, Leesa and Magnuson, Mark A and Jacobson, David A},
title = {The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults},
journal = {eLife},
year = {2024},
volume = {12},
doi = {10.7554/elife.89967}
}
EUVIMED